Study Study design / N Treatment Results
Prahbat & Korukonda 201838
RET/ 185a
Mean oral NMP-SR dose: 271.4 mg for mean 18 weeks for unexplained RPL 262.5 mg for mean 19 weeks for cervical factor 311.1 mg for mean 10 weeks for threatened miscarriage (spotting or prior history) In all 185 cases, pregnancy was maintained to week 34 with no adverse outcomes. Two cases of spotting were managed symptomatically.